Evidence map›Paper›PMID 24432883›Full record

ArticleAmerican journal of public health2014

Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008.

Bryce D Smith, Geoff A Beckett, Anthony Yartel, Deborah Holtzman, Nita Patel, John W Ward

Open access · greenAbstract read
In one paragraph

Article in American journal of public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?Liver international : official journal of the International Association for the Study of the Liver · 2018
    Article
  7. Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  8. Article
  9. Hepatitis C Virus Infection in the Older Patient.Infectious disease clinics of North America · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Surgeon general's perspectives.Public health reports (Washington, D.C. : 1974) · 2014
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bryce D SmithBryce D. Smith, Geoff A. Beckett, Deborah Holtzman, and John W. Ward are with the Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA. Anthony Yartel and Nita Patel are with the Centers for Disease Control and Prevention Foundation, Atlanta, GA.
Geoff A Beckett
Anthony Yartel
Deborah Holtzman
Nita Patel
John W Ward
Centers for Disease Control and Prevention · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe examined HCV exposure prevalence and predictors among persons in the United States born during 1945-1965.

methodsWith data from the 1999-2008 National Health and Nutrition Examination Survey, we calculated the proportion of persons born during 1945-1965 who tested positive for HCV antibody (anti-HCV) and analyzed the prevalence by sociodemographic and behavioral risk factors.

resultsAnti-HCV prevalence in the 1945-1965 birth cohort was 3.2% (95% confidence interval [CI] = 2.8%, 3.8%), substantially higher than among other adults (0.9%). Within the cohort, anti-HCV prevalence was higher among non-Hispanic Blacks (6.4%; 95% CI = 5.3%, 7.7%), persons with injection drug use histories (56.8%; 95% CI = 48.4%, 64.8%), and persons with elevated alanine aminotransferase levels (12.7%; 95% CI = 10.7%, 15.1%). Injection drug use (adjusted odds ratio = 98.4; 95% CI = 58.8, 164.5) was the strongest anti-HCV prevalence predictor. Among anti-HCV-positive persons, 57.8% reported having 2 or more alcoholic drinks daily.

conclusionsWith the high prevalence of HCV among persons born during 1945-1965, the increasing morbidity and mortality associated with HCV, and reductions in liver cancer and HCV-related mortality when HCV is eradicated, it is critically important to identify persons with HCV and link them to appropriate care.

Indexed as

HepacivirusAdultAgedCohort StudiesConfidence IntervalsFemaleForecastingHealth SurveysHepatitis CHepatitis C AntibodiesHumansMaleMiddle AgedNutrition SurveysPrevalenceRisk FactorsHepatitis C Antibodies

Identifiers

PMID24432883
PMCPMC3953797
OpenAlexW2095952284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.